| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |